Psychiatry Investig > Volume 19(12); 2022 > Article |
|
Availability of Data and Material
The datasets generated or analyzed during the study are available from the corresponding author on reasonable request.
Conflicts of Interest
Jun Soo Kwon, a contributing editor of the Psychiatry Investigation, was not involved in the editorial evaluation or decision to publish this article. All remaining authors have declared no conflicts of interest.
Author Contributions
Conceptualization: Minah Kim, Ahra Kim, Jun Soo Kwon. Data curation: Taekwan Kim, Minji Ha, Silvia Kyungjin Lho, Sun-Young Moon. Formal analysis: Ahra Kim, Minji Ha, Taekwan Kim. Funding acquisition: Minah Kim, Jun Soo Kwon. Investigation: all authors. Methodology: Ahra Kim, Minji Ha, Taekwan Kim. Project administration: Jun Soo Kwon. Resources: Minah Kim, Jun Soo Kwon. Software: Ahra Kim. Supervision: Minah Kim, Jun Soo Kwon. Validation: Minah Kim, Jun Soo Kwon. Visualization: Ahra Kim. Writing—original draft: Ahra Kim. Writing—review & editing: Minji Ha, Taekwan Kim, Sunghyun Park, Silvia Kyungjin Lho, Sun-Young Moon, Minah Kim, Jun Soo Kwon.
Funding Statement
Funding was provided by the Basic Science Research Program through the National Research Foundation of Korea (NRF) and by the KBRI Basic Research Program through the Korea Brain Research Institute, funded by the Ministry of Science & ICT (grant nos. 2019R1C1C1002457, 2020M3E5D9079910, and 21-BR-03-01).
FEP (N=39) | CHR (N=78) | HCs (N=110) |
Statistical analysis† |
|||
---|---|---|---|---|---|---|
F/χ2 | p | |||||
Age (yr) | 23.03±5.63 | 20.53±3.65 | 24.92±6.75 | 13.699 | <0.001** | |
Sex (male/female) | 17/22 | 57/21 | 69/41 | 9.704 | 0.008* | |
Handedness (right/left) | 34/5 | 70/8 | 104/6 | 2.588 | 0.274 | |
IQ | 98.67±13.51 | 107.79±12.71 | 112.89±12.29 | 18.515 | <0.001** | |
PANSS | ||||||
Positive symptoms | 16.38±4.89 | |||||
Negative symptoms | 16.97±4.85 | |||||
General symptoms | 34.56±6.92 | |||||
SOPS | ||||||
Positive symptoms | 9.82±3.76 | |||||
Negative symptoms | 13.37±6.60 | |||||
Disorganization | 4.04±2.78 | |||||
General symptoms | 6.81±4.39 | |||||
GAF | 46.54±9.96 | 51.86±9.72 |
Brain network |
Connectivity strengths |
F | Cluster p-FDR corrected | T | p | ||||
---|---|---|---|---|---|---|---|---|---|
FEP | HCs | CHR | |||||||
FEP vs. HCs | |||||||||
Cluster A | 5.83 | 0.001** | |||||||
SN1-ADMN | 0.033±0.255 | 0.213±0.217 | -4.01 | <0.001** | |||||
SN1-CEN | 0.292±0.243 | 0.421±0.210 | -2.73 | 0.007* | |||||
SN1-PDMN | 0.042±0.199 | 0.156±0.223 | -2.72 | 0.007* | |||||
SN2-CEN | 0.151±0.191 | 0.230±0.208 | -1.91 | 0.057 | |||||
SN2-PDMN | 0.306±0.214 | 0.251±0.224 | 1.48 | 0.139 | |||||
SN2-ADMN | 0.196±0.193 | 0.237±0.217 | -0.73 | 0.463 | |||||
Cluster B | 1.10 | 0.296 | |||||||
ADMN-CEN | 0.593±0.228 | 0.670±0.249 | -1.45 | 0.147 | |||||
PDMN-CEN | 0.642±0.286 | 0.679±0.246 | -0.28 | 0.776 | |||||
CHR vs. HCs | |||||||||
Cluster C | 3.06 | 0.053 | |||||||
SN1-ADMN | 0.213±0.217 | 0.112±0.218 | -2.99 | 0.003** | |||||
SN1-PDMN | 0.156±0.223 | 0.081±0.202 | -2.42 | 0.016* | |||||
SN2-PDMN | 0.251±0.224 | 0.275±0.227 | 0.84 | 0.401 | |||||
SN1-CEN | 0.421±0.210 | 0.388±0.238 | -1.01 | 0.312 | |||||
SN2-CEN | 0.230±0.208 | 0.212±0.190 | -0.46 | 0.646 | |||||
SN2-ADMN | 0.237±0.217 | 0.227±0.229 | 0.17 | 0.865 | |||||
Cluster D | 3.90 | 0.074 | |||||||
ADMN-CEN | 0.670±0.249 | 0.595±0.237 | -1.85 | 0.065 | |||||
PDMN-CEN | 0.679±0.246 | 0.639±0.267 | -0.66 | 0.507 | |||||
FEP vs. CHR | |||||||||
Cluster E | 1.53 | 0.292 | |||||||
SN1-CEN | 0.292±0.243 | 0.388±0.238 | -1.77 | 0.078 | |||||
SN2-CEN | 0.151±0.191 | 0.212±0.190 | -1.43 | 0.153 | |||||
SN1-ADMN | 0.033±0.255 | 0.112±0.218 | -1.43 | 0.153 | |||||
SN2-ADMN | 0.196±0.193 | 0.227±0.229 | -0.82 | 0.413 | |||||
SN2-PDMN | 0.306±0.214 | 0.275±0.227 | 0.74 | 0.463 | |||||
SN1-PDMN | 0.042±0.199 | 0.081±0.202 | -0.67 | 0.505 | |||||
Cluster F | 0.31 | 0.581 | |||||||
PDMN-CEN | 0.642±0.286 | 0.639±0.267 | 0.25 | 0.802 | |||||
ADMN-CEN | 0.593±0.228 | 0.595±0.237 | 0.08 | 0.938 |